Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Recro Pharma Inc.

    NASDAQ: REPH · Real-Time Price · USD
    2.09
    -0.01 (-0.48%)
    At close: Mar 22, 2022, 5:00 AM

    Recro Pharma Balance Sheet Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 8.1M 14.99M 25.22M
    Short-Term Investments
    		 n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a
    Other Long-Term Assets
    		 1.9M 7.49M 246K
    Receivables
    		 16.58M 15.95M 11.91M
    Inventory
    		 10.26M 10.3M 8.92M
    Other Current Assets
    		 18.53M 14.34M 11.48M
    Total Current Assets
    		 53.46M 55.59M 57.53M
    Property-Plant & Equipment
    		 54.8M 50.37M 57.63M
    Goodwill & Intangibles
    		 43.32M 44.01M 44.91M
    Total Long-Term Assets
    		 100.01M 101.86M 102.79M
    Total Assets
    		 153.47M 157.44M 160.32M
    Account Payables
    		 1.31M 1.47M 2.08M
    Deferred Revenue
    		 n/a n/a 2.31M
    Short-Term Debt
    		 37.86M 8.66M 3.09M
    Other Current Liabilities
    		 10.81M 12.69M 12.56M
    Total Current Liabilities
    		 49.99M 22.81M 17.73M
    Long-Term Debt
    		 4.15M 4.58M 4.93M
    Other Long-Term Liabilities
    		 40.67M 70.19M 95.59M
    Total Long-Term Liabilities
    		 44.82M 74.78M 100.52M
    Total Liabilities
    		 94.81M 97.58M 118.25M
    Total Debt
    		 42.01M 13.24M 103.52M
    Common Stock
    		 1.05M 846K 467K
    Retained Earnings
    		 -278.91M -265.63M -245.75M
    Comprehensive Income
    		 n/a n/a n/a
    Shareholders Equity
    		 58.66M 59.86M 42.06M
    Total Investments
    		 n/a n/a n/a

    Add to Watchlist